Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a small software update applied to this page.
    Difference
    0.0%
    Check dated 2026-08-11T16:49:46.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The Plain Language Summary on the study page has been removed, eliminating the patient-friendly overview of the trial.
    Difference
    0.0%
    Check dated 2026-08-04T12:40:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a maintenance/update to the page. No study content or user-facing information appears to change.
    Difference
    0.0%
    Check dated 2026-07-28T10:46:48.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new page revision label (v3.6.3) was added and the previous label (v3.6.0) was removed, updating the page's version metadata.
    Difference
    0.0%
    Check dated 2026-06-30T03:18:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'); also adjusted the Intervention/Treatment label formatting and updated the page revision to v3.6.0 (from v3.5.5).
    Difference
    0.3%
    Check dated 2026-06-15T23:55:38.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a new build of the ClinicalTrials.gov record with likely minor edits or fixes that do not change the underlying study data.
    Difference
    0.0%
    Check dated 2026-06-09T01:54:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.